familymednews.com
Researchers from the Department of Cellular Biology at the University of Seville and the Seville Institute of Biomedicine (IBiS), Pablo Vicente and Doctor Luisma Escudero, in close collaboration with the researcher Rebecca Burgos and other members of the group of Doctor Rosa Noguera (University of Valencia—INCLIVA, CIBERONC) have published a study aimed at developing new therapies to fight childhood cancer. […]
Continue reading »
Potentially life-saving cancer risk assessment tools are being widely underused by general practices across the UK, according to new research. A team of experts from the University of Exeter’s Medical School has designed a set of risk assessment tools—which can predict the likelihood of undiagnosed cancer based on patients’ symptoms, test results and other clinical information. Now, new NIHR-funded research […]
Continue reading »
John Ryan is just one of the miracles to emerge from the Johns Hopkins cancer unit in Baltimore. An immunotherapy treatment—highly effective in a minority of patients—saved his life after a lung cancer diagnosis. The retired military nuclear reactor specialist will celebrate his 74th birthday in July, and his battle with cancer illustrates the promises and failures of immunotherapy, a […]
Continue reading »
The treatment of cancer tumours is made complex by their microenvironment and the abnormalities of the blood vessels sustaining them. The EU-funded NeoNaNo project has developed methods to improve drug delivery to tumours and improve the efficacy of anticancer therapy. Drug delivery to tumours is difficult. The blood vessels they depend on are abnormally structured, heterogeneously distributed and relatively poorly […]
Continue reading »
Alzheimer’s disease currently affects more than 5.5 million Americans and is one of the costliest diseases to treat, according to the Alzheimer’s Association. Characterized by a buildup of plaque in the brain, few animal models exist that researchers could use to study this devastating disorder. Now, a team of researchers from the University of Missouri, publishing in PLOS ONE, developed […]
Continue reading »